Overview of key quarterly metrics (USD thousands, unless noted):
- Revenue: 427,115; Gross Profit: 260,803; Gross Margin: 61.06%; Operating Income: 99,170; Operating Margin: 23.22%; EBITDA: 99,290; EBITDARatio: 23.25%; Net Income: 35,810; Net Margin: 8.38%; Earnings per Share (basic/diluted): 0.0042; Weighted Avg Shares Outstanding: 8,337,423.
- Efficiency and profitability: EBITDA and operating income are both positive and aligned with a high gross margin, reflecting effective cost control within selling, general and administrative (SG&A) expenses (SG&A: 161,633).
- Cash flow and liquidity: Net cash provided by operating activities: 212,661; Free cash flow: 212,661; Cash and cash equivalents: 1,259,281; Current assets: 2,336,244; Current liabilities: 438,051; Current ratio ≈ 5.33x, indicating strong short-term liquidity.
- Balance sheet health: Total assets: 2,336,244; Total liabilities: 438,051; Total stockholders’ equity: 1,898,193; Net debt: -1,259,281 (net cash position).
- Capital allocation: No long-term debt; no share repurchase or dividend activity disclosed for the quarter; cash generation is retained on balance sheet.
- YoY and QoQ momentum (per provided earnings data): Revenue YoY: 293.74%; QoQ: 311.09%; Gross Profit YoY: 256.42%; QoQ: 279.18%; Operating Income YoY: 318.37%; QoQ: 3,885.93%; Net Income YoY: 164.86%; QoQ: 177.34%; EPS YoY: 290.91%; QoQ: 173.68%.
- Note: The reported YoY/QoQ growth magnitudes appear outsized relative to the quarterly revenue base and should be interpreted with caution given the relatively small quarterly scale and potential data normalization effects in the four-quarter aggregation.